The Use of Glucose Polymer (Icodextrin) in Peritoneal Dialysis: An Overview

Hain H. , Kessel M. Aspect of new solutions for peritoneal dialysis. Nephrol Dial Transplant 1987; 2: 67–72.

Ota K. , Mineshima M. , Watanabe N. , Naganuma S. Functional deterioration of the peritoneum: does it occur in the absence of peritonitis? Nephrol Dial Transplant 1987; 2: 30–3.

Dobbie J.W. New concepts of molecular biology and ultrastructural pathology of the peritoneum; their significance for peritoneal dialysis. Am J Kidney Dis 1990; 15: 97–109.

Lamb E. , Cat tell W.R. , Dawney A. Glycated albumin in serum and dialysate of patients on CAPD. Clin Sci 1993; 84: 619–26.

Kiil F. Mechanism of osmosis. Kidney Int 1982; 21: 303–8.

Mistry C.D. , Gokal G. The use of glucose polymer in CAPD: essential physiological and clinical conclusions. In: Ota K. , Maher J.F. , Winchester J.F. , Hirszel P. , eds. Current concepts in peritoneal dialysis. Amsterdam: Elsevier Science, 1993: 138–42.

Mistry C.D. , Mallick N.P. , Gokal R. Ultrafiltration with isosmotic solution during long peritoneal dialysis exchanges. Lancet 1987; ii: 178–82.

Mistry C.D. Glucose polymer as an osmotic agent in continuous peritoneal dialysis. MD thesis. London: University of London, 1989: 1–300.

Mistry C.D. , Gokal R. Can ultrafiltration occur with a hyposmolar solution in peritoneal dialysis? The role for “colloid” osmosis. Clin Sci 1993; 85: 495–500.

Weser E. , Sleisenger M.H. Metabolism of circulating disaccharides in man and in the rat. J Clin Invest 1967; 46: 499–505.

Van Handle E. Trehalase and maltase in the serum of vertebrates. Comp Biochem Physiol 1968; 26: 555–61.

Bittencourt H. , Sleisenger M.H. , Weser E. Studies of serum and tissue maltase in the rat. Gastroenterology 1968; 57: 410.

Mistry C.D. , Gokal R. A single daily overnight (12 hr dwell) use of 7.5% glucose polymer (Mw 18,700; Mn 7,300) + 0.35% glucose solution: a 3-month study. Nephrol Dial Transplant 1993; 8: 443–7.

Mistry C.D. , Gokal R. , Peers M.A. Midas Study Group. A randomised multicentre clinical trial comparing isosmolar dextrin 20 with hyperosmolar glucose solutions in continuous ambulatory peritoneal dialysis (CAPD): a six month study. Kidney Int 1994 (in press).

Topley N. , Alobaidi H.M. , Favies M. , Coles G.A. , Williams J.D. , Lloyds D. The effect of dialysate on peritoneal phagoctye oxidative metabolism. Kidney Int 1988; 34: 404–11.

Alobaidi H.M. , Coles G.A. , Davies M. , Lloyd D. Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function Nephrol Dial Transplant 1986; 1: 16–21.

Liberek T. , Topley N. , Mistry C.D. Cell function and viability in glucose polymer peritoneal dialysis fluids. Perit Dial Int 1993; 13: 104–11.

deFijter C.W.A. , Verbrugh H.A. , Oe P.L. Biocompatibility of a glucose polymer containing peritoneal dialysis fluid. Am J Kidney Dis 1993; 21: 411–18.

Rooney O.B. , Smyth J.V. , Hilker V.F. , Gokal R. , Walker M.G. Glucose polymer in peritoneal dialysis -in vitro mesothelial cell study (Abstract). Nephrol Dial Transplant 1994 (in press).

Jörres A. , Gahl G.M. , Topley N. In vitro biocompatibility of alternative CAPD fluids: comparison of biocarbonate buffered glucose and glucose polymer based solutions. Nephrol Dial Transplant 1994 (in press).